30 results about "Estrogen secretion" patented technology

The invention provides hair loss preventing and hair growth promoting shampoo and a preparation method thereof, and relates to the field of daily chemicals. The shampoo comprises the following raw materials of piroctone olamine, a radix gentianae extract, ginsenoside CK, diaminopyrimidine oxide, a ginseng root extract, a ginger root extract, a cordyceps militaris extract, a fructus forsythiae fruit extract, a radix sophorae yellowish sophora extract, arginine, Vit B6, a surfactant, a preservative, a hair conditioning agent, a chelating agent, a thickening agent, a pH-regulating agent, a flavoring agent, a freshener, a heat sensing agent and water. The shampoo is free from any hormones and illegal drugs, safe and healthy, and the components are in composite coordination, so that blood circulation can be promoted, hair mother cells are revived, estrogen secretion is restrained, scalp microenvironment is improved, inflammatory factor release is restrained, energy supply is reinforced, andfurther, the hair loss preventing effect is reinforced.

The invention discloses a progesterone composite preparation for regulating and controlling estrus of a cow. The progesterone composite preparation is prepared by the following steps of: dissolving progesterone with edible vegetable oil to prepare solution, every milliliter of which contains 20mg of progesterone; dissolving estradiol with sterilized edible vegetable oil to prepare the solution, every milliliter of which contains 10mg of estradiol; and preparing the progesterone composite preparation from 75.00 to 87.50 weight percent of the solution of the progesterone, 8.75 to 10.00 weight percent of the solution of the estradiol and 2.50 to 6.25 weight percent of the edible vegetable oil. The progesterone composite preparation comprises estrogen and progesterone, is injected for regulating and controlling the estrus of the cow, and can obviously improve the estrus synchronization rate and the estrus conception rate of the cow. When used for pre-processing, the progesterone composite preparation can improve the activity of the ovary of the processed cow and the sensitivity to gonadotropic hormone so as to stimulate estrogen secretion and promote follicular development and can prevent insufficient secretion of the progesterone of the processed cow so as not to affect the sexual desire and the estrus of the cow.

A Chinese herba preparation for recuperating and curing ovarian hypoplasia of young girls or adult women is hot drink particles or a tea bag or a granular preparation consisting of kudzu roots, hawthorn, soya beans, red beans, black beans, fructus ligustri lucidi, eclipta alba, honeysuckle, Chinese rose, raw liquorice, dried tangerine or orange peels, fructus amomi, folium ginseng, dipsacus roots, eucommia bark, mistletoe, Japanese raspberry roots, winged euonymus twig, radix trichosanthis, pearl powder, yam flour, medicine beans and a packaging material. The Chinese herba preparation is used for preventing, recuperating and curing diseases including ovarian dysplasia or retardation of the young girls, ovarian hypofunction or hyperfunction, too little or too much estrogen secretion and ovarian and uterus dysgenesis of young married women, premature ovarian failure of older women, and barrenness of fertile women due to hypoplasia of ovum of ovarian, is used for moistening skin, retaining youthful looks and eliminating macula, and has the advantages that total effective rate of clinical recuperating and curing reaches 100% and the like.

The invention provides breast enhancement cream, a preparation method thereof and a use method of the cream, and relates to the technical field of medicine cosmetics. The breast enhancement cream comprises, by weight, 5-10 parts of soy isoflavone extracts, 0.5-5 parts of cowherb seed extracts, 0.5-5 parts of edible kudzuvine root extracts and 5-10 parts of vitamin E. The technical problem of fitness harm caused by surgical breast enhancement or breast enhancement by oral administration of oestrogen medicines is relieved. According to the breast enhancement cream, the soy isoflavone extracts, the cowherb seed extracts, the edible kudzuvine root extracts and the vitamin E cooperate with each other, estrogen secretion can be stimulated, mammary glands can be activated to generate more breastsubcutaneous fat, and mastauxy is promoted. Moreover, in-vivo garbage can be removed, microcirculation is improved, skin elasticity is enhanced, so that breasts are firm and plump, and female curve charm is highlighted.

The application discloses estrogen effects of a Ganoderma lucidum component GL-1 and preliminary discussion of an action mechanism thereof. A computer-assisted simulation computation is used for computing binding capability of GL-1 and an estrogen acceptor, a MTT method is used for detecting influences of GL-1 on proliferation of MCF-7 cells and MDA-MB-231 cells, influences of GL-1 on proliferation of MCF-7 cells induced by estrogen as well as influences of an estrogen acceptor inhibitor ICI182,780 on proliferation of MCF-7 cells induced by GL-1; Western blot is used for detecting expression conditions of ER alpha and ER beta monoclonal antibodies. Results show that the Ganoderma lucidum component GL-1 and an estrogen acceptor beta have good combination capability, and Ganoderma lucidum component GL-1 has estrogen-like effects, can be combined with the estrogen acceptor, and influences estrogen secretion and ER beta expression.

The invention discloses a production method of soy isoflavone with high content of genistin. The production method comprises the following steps: crushing a raw material namely soybean meal, leaching by using ethanol, filtering and screening by using a screening machine, distilling to recover ethanol, precipitating isoflavone by using n-butyl alcohol, filtering to separate out a precipitation solid-phase material generated by the isoflavone in an n-butyl alcohol solution, performing washing separation and purification for the first time, and performing washing separation and purification for the second time. The production method disclosed by the invention has the positive effects that the purity of the obtained soy isoflavone is more than or equal to 90% and the content of genistin is more than or equal to 80%. The content of genistin is improved, and the soy isoflavone with high content of genistin has exact curative effects of improving the development of female secondary sex characteristics, preventing and curing climacteric syndromes, preventing female senile dementia and height atrophy, preventing and curing cancers related to estrogen secretion and the like. Therefore, the misgiving of consumer groups on the medical healthcare function of soy isoflavone is eliminated, and the production method disclosed by the invention can play an active promotion effect on the further development of the soy isoflavone industry.

The invention discloses a pearl soybean calcium soft capsule for female, and the pearl soybean calcium soft capsule for female comprises a capsule casing and content sealed in the capsule casing, wherein the content is liquid or semisolid with a health-care function; the thickness of the capsule casing is 0.2-2mm, and the capsule casing is prepared from the following components in parts by weight: 30 to 70 parts of gelatin, 10 to 50 parts of plasticizer, 5 to 15 parts of water, and 0.1 to 3 parts of pigment; and the content is prepared from the following components in parts by weight: 5 to 15parts of soybean extract, 20 to 40 parts of calcium carbonate, 1 to 5 parts of pearl powder, 1 to 5 parts of suspending agent, and 50 to 80 parts of vegetable oil. The capsule has the function of increasing the bone mineral density by supplying isoflavone and the calcium element in the pearl powder and increasing the calcium carbonate. Health-care function evaluation tests prove that the product can be used for remarkably enhancing the immunity of the female, promoting the skin capillary blood circulation of the female, and effectively promoting the estrogen secretion. The product is easily absorbed by a human body in a capsule mode.

An embodiment of the invention discloses application of chemical components of Herba Ecliptae to phytoestrogens, in particular to application of Herba Ecliptae extracts to preparation of medicines for treatment and/or prevention of estrogen secretion abnormality related diseases. The invention further relates to a pharmaceutical composition for treatment and/or prevention of estrogen secretion abnormality related diseases. The pharmaceutical composition comprises the Herba Ecliptae extracts and a medically acceptable carrier or excipient. According to researches, compounds obtained from Herba Ecliptae have different degrees of phytoestrogen effects. Expectably, the compounds or the Herba Ecliptae extracts and the pharmaceutical composition containing the compounds can be used for treatment and/or prevention of estrogen secretion abnormality related diseases and can be further applied to preparation of medicines for treatment and/or prevention of estrogen secretion abnormality related diseases.

The invention discloses a health food for preventing female climacteric syndrome. The health food is characterized by including the following materials in parts by weight: 14-20 parts of mint, 9-10 parts of exocarpium citri rubrum, 9-17 parts of semen citri reticulatae, 3-8 parts of fructus arctii, 1-4 parts of pubescent holly root, 2-5 parts of amino acid, 1-2 parts of chitin, 3-6 parts of radix puerariae, 14-18 parts of purple sweet potato, 20-30 parts of licorice, 1-8 parts of a sweetening agent, 2-8 parts of an acidic salt, 15-26 parts of starch, and 3-7 parts of fatty acid. The health food has the beneficial effects that: natural ingredients of the materials are scientifically extracted, and then are reasonably combined to prepare the health food which can be easily digested and absorbed by middle and old aged women; and the effective active ingredients are allowed to scavenge free radicals through adjusting the body immunity and activating the estrogen secretion level in middle and old aged women bodies, so as to reach the effects of preventing oxidation, delaying senescence and delaying climacteric syndrome.

The invention discloses a health food for relieving middle-aged female climacteric syndrome. The health food is characterized by including the following materials in parts by weight: 14-20 parts of mint, 3-6 parts of a flavoring agent, 9-13 parts of soybean, 1-3 parts of angelica, 1-2 parts of cinnamomum cassia, 18-25 parts of a helianthus tuberosus powder, 16-20 parts of a sword bean powder, 8-13 parts of tremella, 3-8 parts of osmanthus fragrans, 1-3 parts of hericium erinaceus, and 3-7 parts of fatty acid. The health food has the beneficial effects that natural ingredients of the materials are scientifically extracted, and then are reasonably combined to prepare the health food which can be easily digested and absorbed by middle and old aged women; and the effective active ingredients are allowed to scavenge free radicals through adjusting the body immunity and activating the estrogen secretion level in middle and old aged women bodies, so as to reach the effects of preventing oxidation, delaying senescence and delaying climacteric syndrome.

The invention discloses a progesterone composite preparation for regulating and controlling estrus of a goat. The progesterone composite preparation is characterized by comprising a spring-winter preparation and a summer-autumn preparation, wherein the spring-winter preparation comprises 85.71 to 86.67 percent of progesterone, 3.00 to 3.43 percent of estradiol and 10.33 to 10.86 percent of edible vegetable oil; and the summer-autumn preparation comprises 68.57 to 80.00 percent of progesterone, 1.00 to 3.30 percent of estradiol and 16.70 to 28.57 percent of edible vegetable oil. When used for pre-processing, the progesterone composite preparation can quickly improve the concentration of the progesterone in the blood of the processed goat in a short time to improve the activity of the ovary of the processed female goat and the sensitivity to gonadotropic hormone so as to stimulate estrogen secretion and promote follicular development and can meet the requirement that the female goat needs a small amount of estrogen and a certain amount of progesterone to act on the sexual centre before representing sexual desire and achieving sexual excitation.

The invention discloses a rose linseed oil tonifying the kidney, regulating menstruation, instant food and health-preserving porridge and a preparation method thereof. The powder is mixed with crushed iron stick yam, black sesame, and millet. Each bag is 50 grams with 15ml linseed oil bag. Among them, roses are a tonic for the uterus, which can promote estrogen secretion, regulate menstruation, and calm menstruation. Pre-stress and menopausal discomfort; linseed oil is the oil with the highest α-linolenic acid content, which has the effects of cleaning and relaxing blood vessels, lowering blood lipids, preventing diabetes and cardiovascular and cerebrovascular diseases, and assisting kidney and regulating menstruation from the perspective of blood circulation; this formula can nourish the kidney and regulate menstruation , enhance women's sexual function, turn the medicine-style tonifying kidney and regulating menstruation into a diet-therapy style, with a thick taste and no bitterness, achieving the purpose of life, convenience and long-lasting.

The invention discloses a pill for regulating gynecological diseases caused by female endocrine dyscrasia, which belongs to the field of traditional Chinese medicines and comprises the following raw materials in parts by weight: 6-9 parts of red ginseng, 10-12 parts of astragalus membranaceus, 5-6 parts of white paeony root, 4-6 parts of liquorice, 6-9 parts of bulbus fritillariae cirrhosae, 4-6 parts of ampelopsis japonica, 12 parts of jujube, 9 parts of ginger, 8-10 parts of cassia twig, 6-9 parts of oyster and 10-12 parts of perilla leaf. The traditional Chinese medicine pill disclosed by the invention can be used for improving the immunity of the organism, improving phlegm-dampness constitution and radically treating chronic rhinitis. The pill disclosed by the invention can be used for radically treating patients with gynecological diseases such as estrogen secretion reduction, irregular menstruation, breast nodules, hyperplasia of mammary glands, breast distending pain and the like.

The invention relates to a traditional Chinese medicine for treatment of climacteric female endocrine disorder. According to an adopted technical scheme, the traditional Chinese medicine is prepared from the following bulk drugs by weight: 10-20 parts of cistanche, 10-20 parts of radix morindae officinalis, 5-10 parts of semen cuscutae, 10-15 parts of eucommia psoralea corylifolia paste, 15-25 parts of raspberry, 10-30 parts of red ginseng, 5-15 parts of glossy privet fruit, 10-30 parts of Herba Ecliptae, 5-20 parts of male silkworm moth, 15-30 parts of Chinese yam, 10-30 parts of Ootheca Mantidis, 10-30 parts of honeycomb, and 10-30 parts of Schisandra chinensis. The traditional Chinese medicine provided by the invention is directed at climacteric female endocrine disorder caused by insufficient estrogen secretion, and the resulted symptoms of rough and oily skin, facial and neck acne, low sexual desire, gynecological diseases, discomfort of the precordial area and other symptoms, and uses the method of nourishing yin and tonifying kidney, reinforcing qi and nourishing blood, promoting blood circulation and regulating menstruation, tonifying spleen and eliminating dampness to reach the purposes of relieving and curing climacteric female endocrine disorder. The traditional Chinese medicine for treatment has the advantages of remarkable curative effect, pure Chinese medicinal materials, no chemical component or hormone, no toxicity or side effect, quick effect and low price.

Use of chemical ingredients in Cynomorium as phytoestrogen is provided by the present invention. Particularly, use of Cynomorium, extracts of Cynomorium, or at least one ingredient chosen from chrysophanol, emodin, catechin, (−)-epicatechin-3-O-gallate, naringenin-4′-O-glucopyranoside, and phlorizin, in manufacturing medicaments for treating and/or preventing diseases related to insufficient of estrogen secretion in mammal (for example, human), or use in manufacturing medicaments used as phytoestrogens is provided by the present invention. The extracts of Cynomorium, compositions containing extracts of Cynomorium or active ingredients thereof, and methods of treating and/or preventing diseases related to insufficient of estrogen secretion are also provided by the present invention. According to the present invention, Cynomorium, extracts of Cynomorium, active ingredients thereof may be used to treat and/or prevent menopausal syndrome, osteoporosis, degenerative osteoporosis, cardiovascular and cerebrovascular diseases and breast cancer.

The invention discloses a method for preparing a freeze-dried powder injection promoting the estrogen secretion from aloes and pseudo-ginseng. The freeze-dried powder injection is prepared from aloe powder and pseudo-ginseng powder. The method comprises the following steps: at first, mixing the aloe powder and the pseudo-ginseng powder proportionally, and adding distilled water to prepare a mixed solution; taking supernate to be filtered and clarified after standing overnight; adding hydrochloric acid to adjust the pH value to 6.3-6.5, cooling after heat sterilizing; adjusting the pH value of a coolant to 4.2-4.5, ultrafiltering with an ultrafiltration membrane, intercepting a medicated solution with the molecular weight less than or equal to 10,000 Da, respectively filling ampoule bottles with the medicated solution, and freeze-drying. The method breaks through the use range of the aloes to simply expelling toxin and beautifying the skin and relaxing the bowels and lowering lipid, the freeze-dried powder injection is prepared from the alones and the pseudo-ginseng, so that the medicinal field is widened to promote the estrogen secretion to treat. Tests show that the freeze-dried preparation can promote the estrogen and androgen secretion, the treatment effect is outstanding, no toxic or side effect exists, and the medicinal treatment field of the aloes is greatly widened.

The invention relates to application of astaxanthin, in particular to application of astaxanthin in promoting development of preantral follicles of mice and a preparation. The astaxanthin is added into the in-vitro culture solution of the preantral follicles of the mouse to explore the antioxidant effect and the antioxidant mechanism of the preantral follicles in the follicle development process, and the result shows that the astaxanthin reduces lipid peroxidation in the follicles by improving the expression of antioxidant genes in the follicles and improves the follicle development rate and estrogen secretion, so that the anti-oxidation effect of the follicles is improved. The in-vitro development of the preantral follicles of the mice is promoted, and the result provides reference for the application in the in-vitro culture of follicles of other species.

The invention discloses a health food for regulating female climacteric syndrome. The health food is characterized by including the following materials in parts by weight: 14-20 parts of mint, 9-10 parts of exocarpium citri rubrum, 5-10 parts of mung bean, 9-14 parts of plum powder, 3-6 parts of cherry powder, 2-6 parts of strawberry powder, 1-2 parts of malus pumila powder, 2-3 parts of deer horn, 1-2 parts of pilose antler, 3-6 parts of phytolacca acinosa, 4-8 parts of sophora japonica, 1-5 parts of sophora fruit, 6-9 parts of nidus vespae, 15-26 parts of starch, and 3-7 parts of fatty acid. The health food has the beneficial effects that natural ingredients of the materials are scientifically extracted, and then are reasonably combined to prepare the health food which can be easily digested and absorbed by middle and old aged women; the effective active ingredients are allowed to scavenge free radicals through adjusting the body immunity and activating the estrogen secretion level in middle and old aged women bodies, so as to reach the effects of preventing oxidation, delaying senescence and delaying climacteric syndrome.